July 4, 2017
Statement at the 26th Standing Committee on Patents Item 5 – Patent and health
July 4, 2017
Access to affordable medicines no longer represents a challenge just for the Least Developed and other developing countries; it has also become an increasingly urgent issue for developed countries.The challenge of developing and implementing effective and equitable policy measures for innovation and access to meet public health needs is dynamic in nature, evolving with disease burden, progress in technology and diversification of innovation systems. Adaptive solutions will be needed to address changing and diversified needs.
Download statement